Simplifying Global Compliance
FDAnews Drug Daily Bulletin
New Avastin Tests Add to Confusion Over Use in Breast Cancer
Jan. 31, 2012
In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer — the late-stage, incurable form of the disease.
Los Angeles Times
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing